The latest Xarelto news revolves around the proposed expansion of the drug for some additional problems by Johnson & Johnson and Bayer. Apparently, both companies have stated in a recent WSJ article that they have put forth a planned “initiative includ[ing] two studies to test the anticlotting agent in patients […]